Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2012 May 2;6:85–92. doi: 10.1016/j.provac.2012.04.012

Efficacy of intranasal and spray delivery of adjuvanted live vaccine against infectious bronchitis virus in experimentally infected poultry

Sebastien Deville a, Juliette Ben Arous a,⁎, François Bertrand a, Vladimir Borisov b, Laurent Dupuis a
PMCID: PMC7128841  PMID: 32288918

Abstract

Live vaccines are widely used in the avian industry. Such vaccines can be either injected or delivered on animal mucosa and are usually not adjuvanted. In this study we show that live vaccines efficacy can be improved by formulation with adjuvants in a model of mucosal delivery of live infectious bronchitis vaccine in chicken. Three adjuvant technologies have been tested using intranasal and spray delivery methods to poultry. Those technologies are water in oil in water emulsion, nanoparticles and polymer adjuvants. Intranasal delivery of polymer and nanoparticles adjuvanted live vaccines improved significantly the antibody titer and protection to challenge observed compared to a commercial non-adjuvanted reference. Moreover, spray delivery of the polymer adjuvanted vaccine showed a significantly higher protection compared to the non-adjuvanted reference. Our data demonstrates that the use of MontanideTM adjuvants in the formulation of live poultry vaccines for mucosal delivery can confer to vaccinated animals a significantly improved protection against pathogens.

Keywords: live vaccine, infectious bronchitis, poultry, adjuvant, mucosal delivery, challenge, Montanide

References

  • 1.Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol. 2003;32:567–582. doi: 10.1080/03079450310001621198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dong X.N., Chen Y.H. Marker vaccine strategies candidate C.S.F.V. marker vaccines. Vaccine. 2007;25:205–230. doi: 10.1016/j.vaccine.2006.07.033. [DOI] [PubMed] [Google Scholar]
  • 3.Rauw F., Gardin Y., Palya V., van Borm S., Gonze M., Lemaire S., Van den Berg T., Lambrecht B. Humoral, cell-mediated and mucosal immunity induced by oculo-nasal vaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle disease vaccines. Vaccine. 2009;27:3631–3642. doi: 10.1016/j.vaccine.2009.03.068. [DOI] [PubMed] [Google Scholar]
  • 4.Jacobs A.A., Goovaerts D., Nuijten P.J., Theelen R.P., Hartford O.M., Foster T.J. Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi. Vet Rec. 2000;147:563–567. doi: 10.1136/vr.147.20.563. [DOI] [PubMed] [Google Scholar]
  • 5.Schultz R.D., Thiel B., Mukhtar E., Sharp P., Larson L.J. Age and long-term protective immunity in dogs and cats. J Comp Pathol. 2010;142(1):S102–S108. doi: 10.1016/j.jcpa.2009.10.009. [DOI] [PubMed] [Google Scholar]
  • 6.Frey J. Biological safety concepts of genetically modified live bacterial vaccines. Vaccine. 2007;25:5598–5605. doi: 10.1016/j.vaccine.2006.11.058. [DOI] [PubMed] [Google Scholar]
  • 7.Bhanuprakash V., Indrani B.K., Hosamani M., Balamurugan V., Singh R.K. Bluetongue vaccines: the past, present and future. Expert Rev Vaccines. 2009;8:191–204. doi: 10.1586/14760584.8.2.191. [DOI] [PubMed] [Google Scholar]
  • 8.Dalloul R.A., Lillehoj H.S. Recent advances in immunomodulation and vaccination strategies against coccidiosis. Avian Dis. 2005;49:1–8. doi: 10.1637/7306-11150R. [DOI] [PubMed] [Google Scholar]
  • 9.Rauw F., Gardin Y., Palya V., Anbari S., Gonze M., Lemaire S., Van den Berg T., Lambrecht B. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Vet Immunol Immunopathol. 2010;134:249–258. doi: 10.1016/j.vetimm.2009.10.028. [DOI] [PubMed] [Google Scholar]
  • 10.Aucouturier J., Ganne V., Laval A. Efficacy and safety of new adjuvants. Ann N Y Acad Sci. 2000;916:600–604. doi: 10.1111/j.1749-6632.2000.tb05343.x. [DOI] [PubMed] [Google Scholar]
  • 11.Cavanagh D. Coronavirus avian infectious bronchitis virus. Vet Res. 2007;38:281–297. doi: 10.1051/vetres:2006055. [DOI] [PubMed] [Google Scholar]
  • 12.Jang SI, Lillehoj HS, Lee SH, Lee KW, Park MS, Bauchan GR, Lillehoj EP, Bertrand F, Dupuis L, Deville S. Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection. Vet Parasitol 2010; 172(3-4):221-8. [DOI] [PubMed]
  • 13.Macdonald J.W., Randall C.J., McMartin D.A., Dagless M.D. Immunity following inoculation of the H120 and H52 vaccine strains of infectious bronchitis virus into the crop of the domestic fowl. Avian Pathol. 1983;12:379–388. doi: 10.1080/03079458308436181. [DOI] [PubMed] [Google Scholar]
  • 14.Glisson J, Kleven S. Vaccines for veterinary application. In Poultry vaccines 1st ed. Oxford: Butterworth-Heinemann Ltd, 1993, p165-179.
  • 15.Branton S.L., Roush W.B., Lott B.D., Evans J.D., Dozier W.A., 3rd, Collier S.D., Bearson S.M., Bearson B.L., Pharr G.T. A self-propelled, constant-speed spray vaccinator for commercial layer chickens. Avian Dis. 2005;49:147–151. doi: 10.1637/7258-081004R. [DOI] [PubMed] [Google Scholar]
  • 16.Jang S.I., Lillehoj H.S., Lee S.H., Lee K.W., Lillehoj E.P., Bertrand F., Dupuis L., Deville S. Montanide™ IMS 1313 N VG PR nanoparticle adjuvant enhances antigen-specific immune responses to profilin following mucosal vaccination against Eimeria acervulina. Vet Parasitol. 2011;182:163–170. doi: 10.1016/j.vetpar.2011.05.019. [DOI] [PubMed] [Google Scholar]
  • 17.Jang S.I., Lillehoj H.S., Lee S.H., Lee K.W., Lillehoj E.P., Bertrand F., Dupuis L., Deville S. Mucosal immunity against Eimeria acervulina infection in broiler chickens following oral immunization with profilin in Montanide™ adjuvants. Exp Parasitol. 2011;129(1):36–41. doi: 10.1016/j.exppara.2011.05.021. [DOI] [PubMed] [Google Scholar]
  • 18.Corbanie E.A., Matthijs M.G., van Eck J.H., Remon J.P., Landman W.J., Vervaet C. Deposition of differently sized airborne microspheres in the respiratory tract of chickens. Avian Pathol. 2006;35:475–485. doi: 10.1080/03079450601028845. [DOI] [PubMed] [Google Scholar]
  • 19.Corbanie E.A., Remon J.P., Van Reeth K., Landman W.J., van Eck J.H., Vervaet C. Spray drying of an attenuated live Newcastle disease vaccine virus intended for respiratory mass vaccination of poultry. Vaccine. 2007;25:8306–8317. doi: 10.1016/j.vaccine.2007.09.049. [DOI] [PubMed] [Google Scholar]
  • 20.Purswell J.L., Mayer J.J., Evans J.D., Branton S.L., Davis J.D. Eye surface area and dosage rates for spray vaccination. Avian Dis. 2010;54:1310–1315. doi: 10.1637/9478-072110-ResNote.1. [DOI] [PubMed] [Google Scholar]
  • 21.Guy J.S., Barnes H.J., Smith L. Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Dis. 1991;35:348–355. [PubMed] [Google Scholar]
  • 22.Hopkins S.R., Yoder H.W., Jr. Reversion to virulence of chicken-passaged infectious bronchitis vaccine virus. Avian Dis. 1986;30:221–223. [PubMed] [Google Scholar]

Articles from Procedia in Vaccinology are provided here courtesy of Elsevier

RESOURCES